In HCT116, HT29 and HepG2, etc., over-expression of UCP2 plays an anti-apoptotic role by modulating the generation of intracellular ROS after tumor cells are exposed to chemotherapeutic agents [7], [13], [14]. Here, UCP2 is linked to neoplasm.